Corix Bioscience, Inc. (CXBS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 9, 2025, 8:00 PM EDT
Corix Bioscience Market Cap
Corix Bioscience has a market cap or net worth of $20.00 as of September 11, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
20.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 14, 2017, Corix Bioscience's market cap has decreased from 6.81M to 20.00, a decrease of -100.00%. That is a compound annual growth rate of -79.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2025 | 20.00 | - |
| Dec 31, 2024 | 20.00 | -99.00% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |